CN108794425A - Fluorescence probe and its application - Google Patents

Fluorescence probe and its application Download PDF

Info

Publication number
CN108794425A
CN108794425A CN201810486699.5A CN201810486699A CN108794425A CN 108794425 A CN108794425 A CN 108794425A CN 201810486699 A CN201810486699 A CN 201810486699A CN 108794425 A CN108794425 A CN 108794425A
Authority
CN
China
Prior art keywords
alkyl
fluorescence
fluorescence probe
cell
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810486699.5A
Other languages
Chinese (zh)
Other versions
CN108794425B (en
Inventor
孙红霞
陈宏博
唐亚林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Chemistry CAS
Original Assignee
Institute of Chemistry CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Chemistry CAS filed Critical Institute of Chemistry CAS
Priority to CN201810486699.5A priority Critical patent/CN108794425B/en
Publication of CN108794425A publication Critical patent/CN108794425A/en
Application granted granted Critical
Publication of CN108794425B publication Critical patent/CN108794425B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D421/00Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D421/02Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings
    • C07D421/06Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1037Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/104Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with other heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention discloses fluorescence probe and its applications.Wherein, fluorescence probe has structure or its stereoisomer shown in Formulas I, wherein R1For hydrogen, C1‑6Alkyl, phenyl or alkyl-substituted phenyl;R2~R9It independently is hydrogen atom, C1‑6Alkyl, C1‑6Halogenated alkyl, C1‑6Alkoxy or halogen atom;R10And R11It independently is sulfonic group or the C of sulfonic group substitution1‑6Alkyl;X1, X2It independently is carbon, oxygen, sulphur, selenium or tellurium.The specific good biocompatibility of the fluorescence probe, cytotoxicity are low, small advantage is damaged to biological sample, and have good anti-light bleachability, may be implemented effectively to observe the cell sample long period, and do not influenced by intracellular ph value.

Description

Fluorescence probe and its application
Technical field
The present invention relates to analytical chemistry fields, and in particular, to fluorescence probe and its application, more particularly, to fluorescence The fluorescence imaging of the purposes and cell autophagy lysosome of probe, fluorescence probe in targeting intracellular autophagy lysosome fluorescence imaging Method.
Background technology
Lysosome is a kind of very important organelle, and diameter about 200-500nm is almost present in all eukaryocytes In.There are many enzymes and protein, including acid hydrolase, membrane proteolytic enzyme and cathepsin in lysosome, disappears for intracellular Change organ, the macromolecular substances such as various protein of decomposable asymmetric choice net have the function of dissolving or digest.Autophagy lysosome, also known as cell lysis Enzyme body, it is that primary lysosome is merged with the vesica containing the endogenous material i.e. autophagosome from autophagocytosis or lysosome gulps down Phagocyte matter and formed, serve in the cell " street cleaner ", as intracellular organelle and the other structures natueal reduction of staffs and more New usual channel.Autophagy lysosome in normal cell in digestion, decomposition, substitute naturally and risen in some intracellular structures Important function.When cell is by drug effect, radiation exposure and mechanical damage, quantity significantly increases.In lesion In cell also often visible autophagy lysosome.Therefore, by detect autophagy lysosome, can be many diseases diagnosis and treat with Track provides useful information.
Fluorescence probe has the advantages such as easy to operate, high sensitivity, cytotoxicity be small, is caused extensively in field of biological detection General concern and research.Sold currently on the market it is several label lysosomes fluorescence probe such as LysoTracker Red, LysoTracker Green etc., but still lack the probe of commercialized label autophagy lysosome.
Invention content
The present invention is directed at least solve one of the technical problems existing in the prior art.For this purpose, one object of the present invention It is to propose a kind of fluorescence probe, the good biocompatibility of the fluorescence probe, cytotoxicity are low, it is small to be damaged to biological sample, and With good anti-light bleachability, may be implemented effectively to observe the cell sample long period, and not by intracellular ph value It influences.
According to an aspect of the present invention, the present invention provides a kind of fluorescence probes.According to an embodiment of the invention, this is glimmering Light probe has structure or its stereoisomer shown in Formulas I,
Wherein,
R1For hydrogen, C1-6Alkyl, phenyl or alkyl-substituted phenyl;
R2-R9It independently is hydrogen atom, C1-6Alkyl, C1-6Halogenated alkyl, C1-6Alkoxy or halogen atom;
R10And R11It independently is sulfonic group or the C of sulfonic group substitution1-6Alkyl;
X1, X2It independently is carbon, oxygen, sulphur, selenium or tellurium.
Fluorescence probe according to the ... of the embodiment of the present invention, membrane permeability is good, cell need not be fixed, is penetrating etc. Reason carries out specific marker under conditions of keeping cell activity to intracellular autophagy lysosome;There is biocompatibility simultaneously Well, cytotoxicity is low, small advantage is damaged to biological sample, and has good anti-light bleachability, may be implemented to cell The sample long period is effectively observed, and is not influenced by intracellular ph value.In addition, the probe ingredient is simple, detection is easy to operate, Fast, it is expected to become the Universal Dye of detection living cells autophagy lysosome.
In addition, fluorescence probe according to the above embodiment of the present invention can also have following additional technical characteristic:
According to an embodiment of the invention, the alkyl is methyl, ethyl, n-propyl, isopropyl, normal-butyl, isobutyl group, uncle Butyl, amyl, isopentyl, n-hexyl or isohesyl.
According to an embodiment of the invention, the alkyl-substituted phenyl is aminomethyl phenyl or 3,5-dimethylphenyl.
According to an embodiment of the invention, the halogenated alkyl be a fluoromethane, difluoromethane, fluoroform, a bromomethane, Methylene bromide or bromoform.
According to an embodiment of the invention, the alkoxy is methoxyl group, ethyoxyl or propoxyl group.
According to an embodiment of the invention, the halogen atom is fluorine, chlorine, bromine or iodine.
According to an embodiment of the invention, R1For hydrogen or C1-3Alkyl;R2-R9It independently is hydrogen atom, C1-3Alkyl, C1-3 Halogenated alkyl, methoxyl group or halogen atom;R10And R11It independently is sulfonic group, sulfonomethyl or sulfonic group ethyl.
According to an embodiment of the invention, include the structure of one of:
According to another aspect of the invention, the present invention provides fluorescence probes above-mentioned to target intracellular autophagy lysosome Purposes in fluorescence imaging.Since the fluorescence probe membrane permeability and good biocompatibility, cytotoxicity are low, are damaged to biological sample Hinder small advantage, and there is good anti-light bleachability, intracellular autophagy lysosome fluorescence is being targeted using the fluorescence probe The processing such as cell need not be fixed, be penetrating, to intracellular autophagy lysosome under conditions of keeping cell activity in imaging Specific marker is carried out, and may be implemented effectively to observe the cell sample long period, and is not influenced by intracellular ph value. Furthermore, it is necessary to explanation, the fluorescence probe have the advantages that all technical features of aforementioned fluorescent probe and, herein no longer one by one It repeats.
In accordance with a further aspect of the present invention, the present invention provides a kind of methods of the fluorescence imaging of cell autophagy lysosome. According to an embodiment of the invention, this method includes:Fluorescence probe above-mentioned is mixed with solvent, it is molten to obtain fluorescence probe Liquid;The fluorescence probe solution and cell are subjected to contact culture, to obtain the cell of fluorescent marker;And to the fluorescence The cell of label carries out fluorescence imaging.Since the fluorescence probe has membrane permeability and good biocompatibility, cytotoxicity low, right Biological sample damages small advantage, and has good anti-light bleachability, and cell autophagy lyase is carried out using the fluorescence probe The processing such as cell need not be fixed, be penetrating in the fluorescence imaging of body, under conditions of keeping cell activity to it is intracellular from It bites lysosome and carries out specific marker, and may be implemented effectively to observe the cell sample long period, and not by internal pH The influence of value.Furthermore, it is necessary to explanation, the fluorescence probe have the advantages that all technical features of aforementioned fluorescent probe and, This is no longer repeated one by one.
According to an embodiment of the invention, the solvent is molten selected from physiological saline, trishydroxymethylaminomethane-hydrochloride buffer Liquid, phosphatic buffer solution, methanol solution, ethanol solution, acetonitrile solution, dimethyl sulfoxide solution and diformamide solution are extremely Few one kind.
The additional aspect and advantage of the present invention will be set forth in part in the description, and will partly become from the following description Obviously, or practice through the invention is recognized.
Description of the drawings
The above-mentioned and/or additional aspect and advantage of the present invention will become in the description from combination following accompanying drawings to embodiment Obviously and it is readily appreciated that, wherein:
Fig. 1 shows fluorescence imaging schematic diagram according to an embodiment of the invention;
Fig. 2 shows fluorescence imaging schematic diagram according to an embodiment of the invention;
Fig. 3 shows fluorescence imaging schematic diagram according to an embodiment of the invention;
Fig. 4 shows fluorescence imaging schematic diagram according to an embodiment of the invention;
Fig. 5 shows fluorescence imaging schematic diagram according to an embodiment of the invention;
Fig. 6 shows fluorescence imaging schematic diagram according to an embodiment of the invention.
Specific implementation mode
The embodiment of the present invention is described below in detail, examples of the embodiments are shown in the accompanying drawings, wherein from beginning to end Same or similar label indicates same or similar element or element with the same or similar functions.Below with reference to attached The embodiment of figure description is exemplary, and is only used for explaining the present invention, and is not considered as limiting the invention.
Fluorescence probe
According to an aspect of the present invention, the present invention provides a kind of fluorescence probes.According to an embodiment of the invention, this is glimmering Light probe has structure or its stereoisomer shown in Formulas I,
Wherein,
R1For hydrogen, C1-6Alkyl, phenyl or alkyl-substituted phenyl;
R2-R9It independently is hydrogen atom, C1-6Alkyl, C1-6Halogenated alkyl, C1-6Alkoxy or halogen atom;
R10And R11It independently is sulfonic group or the C of sulfonic group substitution1-6Alkyl;
X1, X2It independently is carbon, oxygen, sulphur, selenium or tellurium.
Fluorescence probe according to the ... of the embodiment of the present invention, membrane permeability is good, cell need not be fixed, is penetrating etc. Reason carries out specific marker under conditions of keeping cell activity to intracellular autophagy lysosome;There is biocompatibility simultaneously Well, cytotoxicity is low, small advantage is damaged to biological sample, and has good anti-light bleachability, may be implemented to cell The sample long period is effectively observed, and is not influenced by intracellular ph value.In addition, the probe ingredient is simple, detection is easy to operate, Fast, it is expected to become the Universal Dye of detection living cells autophagy lysosome.
Furthermore, it is necessary to which explanation, the fluorescence probe are also used as laser dye, nonlinear optical material, Yi Jisheng Object sensor etc..
Term " alkyl " indicates that 1-20 carbon atom or 1-10 carbon atom or 1-8 carbon atom or 1-6 carbon are former The univalence hydrocarbyl of the saturated straight chain or branch of son or 1-4 carbon atom or 1-3 carbon atom, wherein alkyl can be independent and be appointed Selection of land is replaced by one or more substituent groups described in the invention.The example of alkyl includes, but is not limited to, methyl (Me ,-CH3), ethyl (Et ,-CH2CH3), n-propyl (n-Pr ,-CH2CH2CH3), isopropyl (i-Pr ,-CH (CH3)2), normal-butyl (n-Bu ,-CH2CH2CH2CH3), isobutyl group (i-Bu ,-CH2CH(CH3)2), sec-butyl (s-Bu ,-CH (CH3)CH2CH3), tertiary fourth Base (t-Bu ,-C (CH3)3), n-pentyl (- CH2CH2CH2CH2CH3), 2- amyls (- CH (CH3)CH2CH2CH3), 3- amyls (- CH (CH2CH3)2), 2- methyl -2- butyl (- C (CH3)2CH2CH3), 3- methyl -2- butyl (- CH (CH3)CH(CH3)2), 3- methyl- 1- butyl (- CH2CH2CH(CH3)2), 2-methyl-1-butene base (- CH2CH(CH3)CH2CH3), n-hexyl (- CH2CH2CH2CH2CH2CH3), 2- hexyls (- CH (CH3)CH2CH2CH2CH3), 3- hexyls (- CH (CH2CH3)(CH2CH2CH3))、2- Methyl -2- amyls (- C (CH3)2CH2CH2CH3), 3- methyl -2- amyls (- CH (CH3)CH(CH3)CH2CH3), 4- methyl -2- penta Base (- CH (CH3)CH2CH(CH3)2), 3- methyl -3- amyls (- C (CH3)(CH2CH3)2), 2- methyl -3- amyls (- CH (CH2CH3)CH(CH3)2), 2,3- dimethyl -2- butyl (- C (CH3)2CH(CH3)2), 3,3- dimethyl -2- butyl (- CH (CH3) C(CH3)3), n-heptyl, n-octyl etc..Term " alkyl " and its prefix " alkane " use here, all include straight chain and branch Saturated carbon chains.Term " alkylene " uses here, indicates that eliminating two hydrogen atoms from linear chain or branched chain saturation hydrocarbons obtains Saturated divalent hydrocarbon radical, such example includes, but is not limited to, methylene, ethylidine, secondary isopropyl etc..
Term " alkoxy " used in the present invention, is related to alkyl, as defined herein, is connected by oxygen atom Onto main carbochain, such example includes, but is not limited to methoxyl group, ethyoxyl, propoxyl group, butoxy etc..And institute It can be substituted or unsubstituted to state alkoxy, and wherein substituent group can be, but be not limited to, deuterium, hydroxyl, amino, halogen, cyanogen Base, alkoxy, alkyl, alkenyl, alkynyl, sulfydryl, nitro etc..
Term " halogenated alkyl " indicates the case where alkyl can be replaced by one or more halogen atoms, such example Include, but is not limited to trifluoromethyl, difluoro-methoxy etc..
In addition, it is necessary to explanation, unless otherwise explicitly pointing out, describing mode as used throughout this document " each ... independently be ", " ... independently be " and " ... be each independently " can be interchanged, and shall be understood in a broad sense, both can be with Refer among the different groups, not influencing mutually, can also indicating identical between expressed specific option between the same symbol Group in, do not influenced mutually between expressed specific option between the same symbol, with R9For, " C1-6Alkyl " and " halogen Substituted alkyl " R between the two9Specific option it is unaffected from each other.
The definition of neutral body chemistry of the present invention and the use of convention are typically referenced to following documents:S.P.Parker,Ed., McGraw-Hill Dictionary of Chemical Terms(1984)McGraw-Hill Book Company,New York;and Eliel,E.and Wilen,S.,"Stereochemistry of Organic Compounds",John Wiley&Sons,Inc.,New York,1994.The compound of the present invention can be comprising asymmetric center or chiral centre, therefore There are different stereoisomers.All stereoisomeric forms in any ratio of the compound of the present invention, including but not limited to, diastereomeric Body, enantiomter, atropisomer and their mixture, such as racemic mixture constitute the part of the present invention.Very More organic compounds all exist with optical active forms, i.e. the plane of their capable Plane of rotation polarised lights.In description optics When reactive compound, prefix D, L or R, S are used for indicating the absolute configuration at molecular chiral center.Prefix d, l or (+), (-) are used for The symbol of compound linearly polarized light rotation is named, (-) or l refer to that compound is left-handed, and prefix (+) or d refer to compound It is dextrorotation.The chemical constitution of these stereoisomers is identical, but their stereochemical structure is different.It is specific three-dimensional Isomers can be enantiomer, isomers mixture be commonly referred to as enantiomeric mixture.50:50 mixture of enantiomers It is referred to as racemic mixture or racemic modification, this may lead to do not have stereoselectivity or stereotaxis in chemical reaction process Property.Term " racemic mixture " and " racemic modification " refer to the mixture of equimolar two enantiomters, lack optics Activity.
It should be noted that for the compound of Formulas I, preparation method can refer to LeslieG.S., Brooker And Frank L.W., JACS, 1935, the synthetic route described in 547-551 can also use its other party well known in the art It is prepared by method.
According to an embodiment of the invention, alkyl is methyl, ethyl, n-propyl, isopropyl, normal-butyl, isobutyl group, tertiary fourth Base, amyl, isopentyl, n-hexyl or isohesyl.
According to an embodiment of the invention, alkyl-substituted phenyl is aminomethyl phenyl or 3,5-dimethylphenyl.
According to an embodiment of the invention, halogenated alkyl is a fluoromethane, difluoromethane, fluoroform, a bromomethane, dibromo Methane or bromoform.
According to an embodiment of the invention, alkoxy is methoxyl group, ethyoxyl or propoxyl group.
According to an embodiment of the invention, halogen atom is fluorine, chlorine, bromine or iodine.
According to an embodiment of the invention, R1For hydrogen or C1-3Alkyl;R2-R9It independently is hydrogen atom, C1-3Alkyl, C1-3 Halogenated alkyl, methoxyl group or halogen atom;R10And R11It independently is sulfonic group, sulfonomethyl or sulfonic group ethyl.
According to an embodiment of the invention, which can include the structure of one of:
The application of fluorescence probe
According to another aspect of the invention, the present invention provides fluorescence probes above-mentioned to target intracellular autophagy lysosome Purposes in fluorescence imaging.Since the fluorescence probe has, membrane permeability is good, good biocompatibility, cytotoxicity are low, to biology The small advantage of sample damage, and there is good anti-light bleachability, targeting intracellular autophagy lyase using the fluorescence probe The processing such as cell need not be fixed, be penetrating, to intracellular autophagy under conditions of keeping cell activity in body fluorescence imaging Lysosome carries out specific marker, and may be implemented effectively to observe the cell sample long period, and not by intracellular ph value Influence.Furthermore, it is necessary to explanation, the fluorescence probe have the advantages that all technical features of aforementioned fluorescent probe and, herein No longer repeat one by one.
In accordance with a further aspect of the present invention, the present invention provides a kind of methods of the fluorescence imaging of cell autophagy lysosome. According to an embodiment of the invention, this method includes:Fluorescence probe above-mentioned is mixed with solvent, it is molten to obtain fluorescence probe Liquid;The fluorescence probe solution and cell are subjected to contact culture, to obtain the cell of fluorescent marker;And to the fluorescence The cell of label carries out fluorescence imaging.Due to the fluorescence probe membrane permeability and good biocompatibility, cytotoxicity it is low, to biology The small advantage of sample damage, and there is good anti-light bleachability, carry out cell autophagy lysosome using the fluorescence probe The processing such as cell need not be fixed, be penetrating in fluorescence imaging, molten to intracellular autophagy under conditions of keeping cell activity Enzyme body carries out specific marker, and may be implemented effectively to observe the cell sample long period, and not by intracellular ph value It influences.Furthermore, it is necessary to explanation, the fluorescence probe have the advantages that all technical features of aforementioned fluorescent probe and, herein not It repeats one by one again.
According to an embodiment of the invention, solvent be selected from physiological saline, trishydroxymethylaminomethane-hydrochloric acid buffer solution, Phosphatic buffer solution, methanol solution, ethanol solution, acetonitrile solution, dimethyl sulfoxide solution and diformamide solution are at least It is a kind of.Wherein, it should be noted that " methanol solution " can be pure methanol, can also be that first alcohol and water is mixed with arbitrary proportion Close obtained solution.Similarly, " ethanol solution ", " acetonitrile solution ", " dimethyl sulfoxide solution " and " diformamide solution " is also such as This, this is no longer going to repeat them.
According to an embodiment of the invention, trishydroxymethylaminomethane-hydrochloric acid buffer solution and phosphatic buffer solution PH value is 6.2-8.2, and concentration is 0-50mmol/L.The pH value of buffer solution and intracellular pH value are close as a result, with cell Good biocompatibility.
Below with reference to specific embodiment, the present invention will be described, it should be noted that these embodiments are only explanation Property, and be not considered as limiting the invention.
The solution of the present invention is explained below in conjunction with embodiment.It will be understood to those of skill in the art that following Embodiment is merely to illustrate the present invention, and should not be taken as limiting the scope of the invention.Particular technique or item are not specified in embodiment Part, according to technology described in document in the art or condition, (such as with reference to works such as J. Pehanorm Brookers, Huang Peitang etc. is translated 's《Molecular Cloning:A Laboratory guide》, the third edition, Science Press) or carry out according to product description.Agents useful for same or instrument Production firm person is not specified, being can be with conventional products that are commercially available, such as can purchase from Sigma companies.
Instrument in following embodiments for observing cell fluorescence is laser confocal microscope (OLYMPUS FV1000- IX81(Olympus,Japan))。
Embodiment 1
The fluorescence probe (1) and LysoTracker Red probes for being utilized respectively the embodiment of the present invention carry out fluorescence to cell Imaging, it is specific as follows:
(1) fluorescence probe (1) and LysoTracker Red probes are dissolved respectively with a small amount of dimethyl sulfoxide (DMSO);
(2) two kinds of fluorescence probe solution of step (1) are added separately in culture medium, are each configured to dense containing 10 μM The culture solution of the culture solution of the fluorescent dye 1 of degree and the LysoTracker Red of 1.0 μM of concentration;
(3) culture solution for pipetting 1mL steps (2) preparation respectively with liquid-transfering gun, being separately added into culture has HEK293 cells In culture dish, and put it into 37 DEG C, 5%CO230min is cultivated in incubator;
(4) cell after culture is washed three times with PBS respectively, it is total adds 1mL blank mixed culture mediums progress fluorescence Focal imaging, the results are shown in Figure 1, wherein a is the fluorescence co-focusing imaging schematic diagram of fluorescence probe (1), and b is The fluorescence co-focusing imaging schematic diagram of LysoTracker Red, the fluorescence signal for scheming a are overlapped with the fluorescence signal height of figure b, table Mark substance is lysosome to bright fluorescence probe (1) in the cell.The experimental results showed that fluorescence probe 1 has intracellular lysosome Good targeting.
Embodiment 2
It is utilized respectively the fluorescence probe (2) of the embodiment of the present invention and induces the glimmering of lysosome autophagy process to monitor cell starvation Light is imaged, specific as follows:
(1) fluorescence probe (2) is dissolved respectively with a small amount of ethyl alcohol;
(2) the fluorescence probe solution of step (1) is added in the culture medium containing 0,5% and 10% fetal bovine serum, is matched It is set to the culture solution of the fluorescent dye 2 containing 4 μM of concentration;
(3) culture solution for pipetting 1mL steps (2) preparation respectively with liquid-transfering gun is added separately to containing 0,5% and 10% embryo In the culture dish of the human lung cancer cell A549 of fetal calf serum medium culture, and put it into 37 DEG C, 5%CO2In incubator Cultivate 1h;
(4) cell after culture is washed three times with PBS respectively, it is total adds 1mL blank mixed culture mediums progress fluorescence Focal imaging, the results are shown in Figure 2, wherein a is using culture medium (containing 0 fetal bovine serum) training without fetal bovine serum The fluorescence co-focusing imaging schematic diagram of foster cell, b are the fluorescence using the cell of the medium culture containing 5% fetal bovine serum Co-focusing imaging schematic diagram, c are to be shown using the fluorescence co-focusing imaging of the cell of the medium culture containing 10% fetal bovine serum It is intended to, with the increase of fetal bovine serum concentration, the fluorescence signal of fluorescence probe (2) in the cell gradually weakens, and shows embryo Bovine serum concentration increases, and cell hunger intensity weakens, and intracellular autophagy lysosome is reduced, the experimental results showed that 2 energy of fluorescence probe The variation of enough hungry induction living cells lysosome autophagy of detection.
Embodiment 3
It is utilized respectively the fluorescence probe (3) of the embodiment of the present invention and induces the glimmering of lysosome autophagy process to monitor cell starvation Light is imaged, specific as follows:
(1) fluorescence probe (3) is dissolved respectively with a small amount of methanol;
(2) the fluorescence probe solution of step (1) is added in the blank cultures without fetal bovine serum, is respectively configured At the blank culture solution of the fluorescent dye 3 containing 5 μM of concentration;
(3) the blank culture solution for pipetting 1mL steps (2) preparation respectively with liquid-transfering gun, is added separately to carry out 0,0.5 and In the culture dish for the Cervical Cancer HeLa Cells that 1 hour Nature enemy is crossed, and put it into 37 DEG C, 5%CO2It is cultivated in incubator 20min;
(4) cell after culture is washed three times with PBS respectively, it is total adds 1mL blank mixed culture mediums progress fluorescence Focal imaging, the results are shown in Figure 3, wherein the fluorescence co-focusing imaging that a is the cervical carcinoma HeLa crossed through 0 hour Nature enemy Schematic diagram, b are the fluorescence co-focusing imaging schematic diagram of the cervical carcinoma HeLa crossed through 0.5 hour Nature enemy, and c is through 1 hour famine The fluorescence co-focusing imaging schematic diagram of processed cervical carcinoma HeLa is starved, with the increase of starvation time, fluorescence probe (3) is thin The fluorescence signal of intracellular gradually increases, and shows to increase with starvation time, and cell hunger intensity enhancing, intracellular autophagy lysosome increases It is more.The experimental results showed that fluorescence probe 3 can detect the variation of hungry induction living cells autophagy lysosome.
Embodiment 4
Fluorescence probe (4) the monitoring Bafilomycin A1 for being utilized respectively the embodiment of the present invention inhibits intracellular lysosome autophagy The fluorescence imaging of process, it is specific as follows:
(1) fluorescence probe (4) is dissolved respectively with a small amount of acetonitrile;
(2) the fluorescence probe solution of step (1) is added in culture medium, is configured to the fluorescent dye containing 20 μM of concentration 4 culture solution;
(3) culture solution for pipetting 1mL steps (2) preparation respectively with liquid-transfering gun, is separately added into 0,200nM and 400nM bars In the culture dish of the human fibrosarcoma cell HT1080 of Buddhist Lip river mycin A1 processing, and put it into 37 DEG C, 5%CO2Incubator Middle culture 2h;
(4) cell after culture is washed three times with PBS respectively, it is total adds 1mL blank mixed culture mediums progress fluorescence Focal imaging, the results are shown in Figure 4, wherein a is the human fibrosarcoma cell handled without Ba Foluo mycins (i.e. 0nM) A1 The fluorescence co-focusing imaging schematic diagram of HT1080, b are the human fibrosarcoma cell HT1080 handled through 200nM Bafilomycin A1s Fluorescence co-focusing imaging schematic diagram, c is the glimmering of the human fibrosarcoma cell HT1080 handled through 400nM Bafilomycin A1s Light co-focusing imaging schematic diagram.With the increase of Ba Foluo mycin concentration, the fluorescence signal of fluorescence probe (4) in the cell is gradual Weaken, shows that intracellular autophagy lysosome is reduced.The experimental results showed that fluorescence probe 4, which can monitor Bafilomycin A1, inhibits thin The variation of intracellular autophagy lysosome.
Embodiment 5
It is utilized respectively lysosome autophagy process in fluorescence probe (5) the monitoring rapamycin inducing cell of the embodiment of the present invention Fluorescence imaging, it is specific as follows:
(1) fluorescence probe (5) is dissolved respectively with a small amount of dimethyl sulfoxide (DMSO);
(2) the fluorescence probe solution of step (1) is added in culture medium, is configured to the fluorescent dye containing 15 μM of concentration 5 culture solution;
(3) culture solution for pipetting 1mL steps (2) preparation respectively with liquid-transfering gun, is added separately to mould with 0,2 and 5 μM of thunder pa In the culture dish of the human breast cancer cell line Bcap-37 of element processing, and put it into 37 DEG C, 5%CO210min is cultivated in incubator;
(4) cell after culture is washed three times with PBS respectively, it is total adds 1mL blank mixed culture mediums progress fluorescence Focal imaging, the results are shown in Figure 5, wherein a is that the fluorescence of the human breast cancer cell line Bcap-37 through 0 μM of rapamycin treatment is copolymerized Burnt imaging schematic diagram, b are the fluorescence co-focusing imaging schematic diagram of the human breast cancer cell line Bcap-37 through 2 μM of rapamycin treatments, c For the fluorescence co-focusing imaging schematic diagram of the human breast cancer cell line Bcap-37 through 5 μM of rapamycin treatments, with rapamycin concentrations Increase, the fluorescence signal of fluorescence probe (5) in the cell gradually increases, and shows intracellular autophagy lysosome increasing.Experiment knot Fruit shows that fluorescence probe 5 has good membrane permeability, can monitor the process of autophagy lysosome in rapamycin inducing cell.
Embodiment 6
Fluorescence probe (6) the monitoring chloroquine for being utilized respectively the embodiment of the present invention inhibits the glimmering of intracellular lysosome autophagy process Light is imaged, specific as follows:
(1) fluorescence probe (6) is dissolved respectively with a small amount of ethyl alcohol;
(2) the fluorescence probe solution of step (1) is added in culture medium, is configured to the fluorescent dye 6 containing 8 μM of concentration Culture solution;
(3) culture solution for pipetting 1mL steps (2) preparation respectively with liquid-transfering gun is added separately to containing 0,2 and 5 μM of chloroquine In the culture dish of human laryngeal cancer cell Hep-2, and put it into 37 DEG C, 5%CO24h is cultivated in incubator
(4) cell after culture is washed three times with PBS respectively, it is total adds 1mL blank mixed culture mediums progress fluorescence Focal imaging, the results are shown in Figure 6, wherein the fluorescence co-focusing imaging signal that a is the human laryngeal cancer cell Hep-2 through 0 μM of chloroquine Figure, b are the fluorescence co-focusing imaging schematic diagram of the human laryngeal cancer cell Hep-2 through 2 μM of chloroquines, and c is that the human laryngeal cancer through 5 μM of chloroquines is thin The fluorescence co-focusing imaging schematic diagram of born of the same parents Hep-2, with the increase of chloroquine concentration, the fluorescence letter of fluorescence probe (6) in the cell Number gradually weaken, shows that intracellular autophagy lysosome is reduced.The experimental results showed that fluorescence probe 6 has good membrane permeability, The process that chloroquine inhibits intracellular autophagy lysosome can be monitored.
It summarizes
Integrated embodiment 1-6 can show that the fluorescence probe membrane permeability of the embodiment of the present invention is good, need not be carried out to cell The processing such as fixed, penetrating carry out specific marker under conditions of keeping cell activity to intracellular autophagy lysosome;Simultaneously should Probe has the advantages that good light stability and cytotoxicity are low, may be implemented effectively to observe the cell sample long period, and not It is influenced by intracellular ph value.In addition, the probe ingredient is simple, detection is easy to operate, quick, is expected to become detection living cells certainly Bite the Universal Dye of lysosome.
In the description of this specification, reference term " one embodiment ", " some embodiments ", " example ", " specifically show The description of example " or " some examples " etc. means specific features, structure, material or spy described in conjunction with this embodiment or example Point is included at least one embodiment or example of the invention.In the present specification, schematic expression of the above terms are not Centainly refer to identical embodiment or example.Moreover, particular features, structures, materials, or characteristics described can be any One or more embodiments or example in can be combined in any suitable manner.
Although an embodiment of the present invention has been shown and described, it will be understood by those skilled in the art that:Not In the case of being detached from the principle of the present invention and objective a variety of change, modification, replacement and modification can be carried out to these embodiments, this The range of invention is limited by claim and its equivalent.

Claims (10)

1. a kind of fluorescence probe, which is characterized in that there is structure or its stereoisomer shown in Formulas I,
Wherein,
R1For hydrogen, C1-6Alkyl, phenyl or alkyl-substituted phenyl;
R2-R9It independently is hydrogen atom, C1-6Alkyl, C1-6Halogenated alkyl, C1-6Alkoxy or halogen atom;
R10And R11It independently is sulfonic group or the C of sulfonic group substitution1-6Alkyl;
X1, X2It independently is carbon, oxygen, sulphur, selenium or tellurium.
2. fluorescence probe according to claim 1, which is characterized in that the alkyl is methyl, ethyl, n-propyl, isopropyl Base, normal-butyl, isobutyl group, tertiary butyl, amyl, isopentyl, n-hexyl or isohesyl;
Optionally, the alkyl-substituted phenyl is aminomethyl phenyl or 3,5-dimethylphenyl.
3. fluorescence probe according to claim 1, which is characterized in that the halogenated alkyl be a fluoromethane, difluoromethane, Fluoroform, a bromomethane, methylene bromide or bromoform.
4. fluorescence probe according to claim 1, which is characterized in that the alkoxy is methoxyl group, ethyoxyl or the third oxygen Base.
5. fluorescence probe according to claim 1, which is characterized in that the halogen atom is fluorine, chlorine, bromine or iodine.
6. fluorescence probe according to claim 1, which is characterized in that R1For hydrogen or C1-3Alkyl;
R2-R9It independently is hydrogen atom, C1-3Alkyl, C1-3Halogenated alkyl, methoxyl group or halogen atom;
R10And R11It independently is sulfonic group, sulfonomethyl or sulfonic group ethyl.
7. fluorescence probe according to claim 1, which is characterized in that include the structure of one of:
8. purposes of the claim 1-7 any one of them fluorescence probe in targeting intracellular autophagy lysosome fluorescence imaging.
9. a kind of method of the fluorescence imaging of cell autophagy lysosome, which is characterized in that including:
Claim 1-7 any one of them fluorescence probes are mixed with solvent, to obtain fluorescence probe solution;
The fluorescence probe solution and cell are subjected to contact culture, to obtain the cell of fluorescent marker;And
Fluorescence imaging is carried out to the cell of the fluorescent marker.
10. according to the method described in claim 9, it is characterized in that, the solvent is selected from physiological saline, trihydroxy methyl amino Methane-hydrochloric acid buffer solution, phosphate buffer solution, methanol solution, ethanol solution, acetonitrile solution, dimethyl sulfoxide solution and two At least one of formamide solution.
CN201810486699.5A 2018-05-21 2018-05-21 Fluorescent probe and application thereof Active CN108794425B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810486699.5A CN108794425B (en) 2018-05-21 2018-05-21 Fluorescent probe and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810486699.5A CN108794425B (en) 2018-05-21 2018-05-21 Fluorescent probe and application thereof

Publications (2)

Publication Number Publication Date
CN108794425A true CN108794425A (en) 2018-11-13
CN108794425B CN108794425B (en) 2021-01-12

Family

ID=64092683

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810486699.5A Active CN108794425B (en) 2018-05-21 2018-05-21 Fluorescent probe and application thereof

Country Status (1)

Country Link
CN (1) CN108794425B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109596585A (en) * 2018-12-03 2019-04-09 贵州大学 A kind of method of new high flux screening lysosome
CN110055054A (en) * 2019-04-09 2019-07-26 中国科学院化学研究所 It is a kind of target tetra- serobila of living cells mitochondria G- fluorescence probe and its application
CN111039897A (en) * 2019-12-26 2020-04-21 中国科学院化学研究所 Fluorescent probes and their use in detection of autophagosomes
CN111100627A (en) * 2019-12-20 2020-05-05 中国科学院化学研究所 Fluorescent probe and application thereof
CN111116573A (en) * 2019-12-31 2020-05-08 中山大学 Near-infrared fluorescent probe for simultaneously detecting DNA and RNA under dual channels and preparation method and application thereof
CN112898228A (en) * 2021-01-18 2021-06-04 中国科学院化学研究所 Mixed assembly based mixed aggregate FRET probes and their use in detecting mitochondrial autophagy
CN113636988A (en) * 2020-04-26 2021-11-12 中国科学院理化技术研究所 Seleno indocyanine green derivative and preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1002873A2 (en) * 1998-06-29 2000-05-24 Ortho-Clinical Diagnostics, Inc. Novel assay systems for vanadium bromoperoxidase
WO2007061768A2 (en) * 2005-11-18 2007-05-31 Phanos Technologies, Inc. Fluorescent membrane intercalating probes and methods for their use
CN107200718A (en) * 2017-05-15 2017-09-26 中国科学院化学研究所 Detect compound, method and the kit of the serobilas of DNA G tetra-

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1002873A2 (en) * 1998-06-29 2000-05-24 Ortho-Clinical Diagnostics, Inc. Novel assay systems for vanadium bromoperoxidase
WO2007061768A2 (en) * 2005-11-18 2007-05-31 Phanos Technologies, Inc. Fluorescent membrane intercalating probes and methods for their use
CN107200718A (en) * 2017-05-15 2017-09-26 中国科学院化学研究所 Detect compound, method and the kit of the serobilas of DNA G tetra-

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张继千;刘学胜;王纯辉: "罗哌卡因对HeLa细胞自噬及自噬溶酶体的影响", 《蚌埠医学院学报》 *
王胜清;申世立;张延如;戴溪; 赵宝祥: "小分子生物硫醇荧光探针研究进展", 《有机化学》 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109596585A (en) * 2018-12-03 2019-04-09 贵州大学 A kind of method of new high flux screening lysosome
CN110055054A (en) * 2019-04-09 2019-07-26 中国科学院化学研究所 It is a kind of target tetra- serobila of living cells mitochondria G- fluorescence probe and its application
CN111100627A (en) * 2019-12-20 2020-05-05 中国科学院化学研究所 Fluorescent probe and application thereof
CN111039897A (en) * 2019-12-26 2020-04-21 中国科学院化学研究所 Fluorescent probes and their use in detection of autophagosomes
CN111039897B (en) * 2019-12-26 2023-04-21 中国科学院化学研究所 Fluorescent probes and their use in detection of autophagy lysosomes
CN111116573A (en) * 2019-12-31 2020-05-08 中山大学 Near-infrared fluorescent probe for simultaneously detecting DNA and RNA under dual channels and preparation method and application thereof
CN113636988A (en) * 2020-04-26 2021-11-12 中国科学院理化技术研究所 Seleno indocyanine green derivative and preparation method and application thereof
CN113636988B (en) * 2020-04-26 2023-07-07 中国科学院理化技术研究所 Seleno indocyanine green derivative and preparation method and application thereof
CN112898228A (en) * 2021-01-18 2021-06-04 中国科学院化学研究所 Mixed assembly based mixed aggregate FRET probes and their use in detecting mitochondrial autophagy
CN112898228B (en) * 2021-01-18 2022-08-02 中国科学院化学研究所 Mixed assembly based mixed aggregate FRET probes and their use in detecting mitochondrial autophagy

Also Published As

Publication number Publication date
CN108794425B (en) 2021-01-12

Similar Documents

Publication Publication Date Title
CN108794425A (en) Fluorescence probe and its application
Majtnerová et al. An overview of apoptosis assays detecting DNA fragmentation
Debnath et al. A lethal cardiotoxic–cytotoxic protein from the Indian monocellate cobra (Naja kaouthia) venom
CN106459125B (en) The Intracellular retention fluorescent chemicals of enzyme spcificity
Song et al. Development of an endoplasmic reticulum-targeting fluorescent probe for the imaging of polarity in living cells and tissues
CN110055054A (en) It is a kind of target tetra- serobila of living cells mitochondria G- fluorescence probe and its application
Morais et al. L-aminoacid oxidase from Bothrops leucurus venom induces nephrotoxicity via apoptosis and necrosis
CN110023289A (en) The removing of the activator and the protein masses including TAU of autophagy tide and phospholipase D and the treatment of protein sickness
US10351707B2 (en) Water-soluble iron ion fluorescent probe and preparation method thereof
Kim et al. COX-2 targeting indomethacin conjugated fluorescent probe
Hu et al. Tuning asymmetric electronic structure endows carbon dots with unexpected huge stokes shift for high contrast in vivo imaging
Kang et al. Alkaline phosphatase-responsive fluorescent polymer probe coated surface for colorimetric bacteria detection
Yu et al. A novel and simple fluorescence probe for detecting main group magnesium ion in HeLa cells and Arabidopsis
CN110057804A (en) Application of the fluorescent carbon point based on N- methyl-o-phenylenediamine hydrochloride in lysosome targeting
Máthé et al. Histological, cytological and biochemical alterations induced by microcystin-LR and cylindrospermopsin in white mustard (Sinapis alba L.) seedlings
CN106491595A (en) Application of the bruceine D in Wnt/Notch signal pathway inhibitor medicines are prepared
JP7140398B2 (en) Nitrobenzene derivative or salt thereof and uses thereof
CN103389382A (en) Signal-enhanced test strip biosensor for detecting histone methylation
CN105838354B (en) Applications of the HQO as monitoring living cells Mitochondria autophagy process fluorescence probe
Tian et al. A highly selective fluorescent probe for detecting glutathione transferases to reveal anticancer-activity sensitivity of cisplatin in cancer cells and tumor tissues
CN111039897B (en) Fluorescent probes and their use in detection of autophagy lysosomes
Bryant et al. Aurone-derived 1, 2, 3-triazoles as potential fluorescence molecules in vitro
CN111100627A (en) Fluorescent probe and application thereof
EP3286200B1 (en) Chemical fluorescent probes for detecting biofilms
Li et al. Synthesis and biological evaluation of stilbene‐based peptoid mimics against the phytopathogenic bacterium Xanthomonas citri pv. citri

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant